Ketamine: an old drug revitalized in pain medicine
PY Tsui, MC Chu - BJA Education, 2017 - academic.oup.com
Ketamine is an anaesthetic drug with unique properties. Discovered in the 1960s, it is known
to produce a dissociative state with sedation, amnesia, and analgesia. It has relatively less …
to produce a dissociative state with sedation, amnesia, and analgesia. It has relatively less …
Ketamine for pain: an update of uses in palliative care
EE Prommer - Journal of palliative medicine, 2012 - liebertpub.com
Ketamine is a lipophilic, general anesthetic. When given at subanesthetic doses, it also has
been found to be an effective analgesic, with efficacy in cancer-associated neuropathic pain …
been found to be an effective analgesic, with efficacy in cancer-associated neuropathic pain …
Ketamine-current uses and future perspectives
AS Jolly, P Jain, J Sood - Journal of Anaesthesiology Clinical …, 2007 - journals.lww.com
Ketamine has been there in clinical anaesthesia practice for more than thirty years. Once
called the complete anaesthetic agent, it has now fallen into disrepute because of various …
called the complete anaesthetic agent, it has now fallen into disrepute because of various …
Ketamine as an analgesic: parenteral, oral, rectal, subcutaneous, transdermal and intranasal administration
RH Kronenberg - Journal of pain & palliative care pharmacotherapy, 2002 - Taylor & Francis
Ketamine is a parenteral anesthetic agent that provides analgesic activity at sub-anesthetic
doses. It is an N-methyl-D-aspartate (NMDA) receptor antagonist with opioid receptor …
doses. It is an N-methyl-D-aspartate (NMDA) receptor antagonist with opioid receptor …
Ketamine for chronic noncancer pain: concerns regarding toxicity
RF Bell - Current opinion in supportive and palliative care, 2012 - journals.lww.com
These findings may have implications for the clinical use of ketamine in chronic noncancer
pain conditions. Until safety issues are resolved, it is suggested that chronic pain treatment …
pain conditions. Until safety issues are resolved, it is suggested that chronic pain treatment …
Safety and efficacy of prolonged outpatient ketamine infusions for neuropathic pain
LR Webster, MJ Walker - American journal of therapeutics, 2006 - journals.lww.com
Ketamine has demonstrated usefulness as an analgesic to treat nonresponsive neuropathic
pain; however, it is not widely administered to outpatients due to fear of such side effects as …
pain; however, it is not widely administered to outpatients due to fear of such side effects as …
Ketamine for the treatment of acute pain
Ketamine is a phencyclidine (PCP) derivative that exerts its effects primarily through N-
methyl-d-aspartate receptor inhibition. 1 At low doses (0.1–0.3 mg/kg), ketamine produces …
methyl-d-aspartate receptor inhibition. 1 At low doses (0.1–0.3 mg/kg), ketamine produces …
Ketamine and magnesium for refractory neuropathic pain: a randomized, double-blind, crossover trial
G Pickering, B Pereira, V Morel, A Corriger, F Giron… - …, 2020 - pubs.asahq.org
Background Ketamine is often used for the management of refractory chronic pain. There is,
however, a paucity of trials exploring its analgesic effect several weeks after intravenous …
however, a paucity of trials exploring its analgesic effect several weeks after intravenous …
Ketamine for refractory chronic pain: a 1-year follow-up study
A Corriger, M Voute, C Lambert, B Pereira, G Pickering… - Pain, 2022 - journals.lww.com
2.1. Study design This prospective, multicenter, and observational study was conducted in
30 French pain clinics (Observational Ketamine And PaIn study Consortium). All included …
30 French pain clinics (Observational Ketamine And PaIn study Consortium). All included …